You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 23, 2024

Details for New Drug Application (NDA): 020918

✉ Email this page to a colleague

« Back to Dashboard

NDA 020918 describes GLUCAGEN, which is a drug marketed by Novo Nordisk and is included in one NDA. It is available from two suppliers. Additional details are available on the GLUCAGEN profile page.

The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
Summary for 020918
Applicant:Novo Nordisk
Ingredient:glucagon hydrochloride
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020918
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLUCAGEN glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 020918 NDA Novo Nordisk 0169-7065 0169-7065-15 1 KIT in 1 KIT (0169-7065-15) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 SYRINGE, GLASS
GLUCAGEN glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 020918 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0053 0597-0053-45 10 VIAL in 1 CARTON (0597-0053-45) / 1 mL in 1 VIAL

Profile for product number 001

Approval Date:Jun 22, 1998TE:RLD:Yes

Profile for product number 002

Approval Date:Jun 22, 1998TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.